Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for the treatment of type 2 diabetes mellitus (brand name Mounjaro) and chronic weight management (brand name Zepbound)
In the same trial, tirzepatide and semaglutide were compared once weekly in the open-label, phase III SURPASS-2 experiment
SKU: RT60 Category: Metabolic Tags: Beginner, Cut, Fat Loss, GLP-3 Series, metabolic peptide, metabolism research, Retatrutide research, Weight Loss / Appetite Control Frequently Bought Together On Backorder In Stock In Stock In Stock In Stock In Stock In Stock In Stock In Stock In Stock Related Products In Stock In Stock In Stock In Stock In Stock In Stock In Stock In Stock In Stock In Stock
Maybe next year, kapag wala nang pressure, well try again